EU Drug Regulator Recommends Approval of Bronchitol
(Corrects to show regulator recommended approval.)
A regulatory panel of the European Medicines Agency recommended approval of a marketing authorization for Pharmaxis Ltd. (PXS)’s Bronchitol drug for cystic fibrosis. The drug should be approved as an add-on to the best standard of care, the agency said in a website statement.
To contact the editor responsible for this story: Phil Serafino at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.